Langmu Medical Leads Drafting of 'Technical Specification for Glaucoma Micro-Stent Drainage System', Setting New Quality Benchmark | Danlu Portfolios

The团体标准 "Technical Specification for Glaucoma Micro-Stent Drainage System" (T/CIET 1469-2025), led by the Eye Hospital of Wenzhou Medical University and primarily drafted by Purevision Medical, has been officially approved, published, and implemented. The introduction of this standard establishes unified technical specifications for the minimally invasive treatment of glaucoma, the world's leading irreversible blinding eye disease, ensuring the safety, efficacy, and controllability of products from the outset. This marks an important step forward in the industry’s path toward standardization and regulation.

As an investment institution focused on the healthcare sector, Danlu Capital consistently pays attention to and supports the growth of enterprises driven by "innovation + standardization." In the future, we will continue to collaborate with outstanding entrepreneurial teams such as Purevision Medical, promoting innovative medical devices from research to clinical application. This will enable more patients to benefit from high-quality treatment solutions and jointly contribute to the sustainable development of the healthcare industry.

The original link is as follows: